Free Trial

Capital Fund Management S.A. Acquires New Shares in Encompass Health Corporation $EHC

Encompass Health logo with Medical background

Key Points

  • Capital Fund Management S.A. has acquired 11,097 shares of Encompass Health Corporation, valued at approximately $1,124,000, during the first quarter.
  • Encompass Health reported earnings per share (EPS) of $1.40 for the last quarter, exceeding analysts' expectations of $1.20.
  • The company declared an increase in its quarterly dividend to $0.19, up from $0.17, with the next payment scheduled for October 15th.
  • MarketBeat previews top five stocks to own in October.

Capital Fund Management S.A. acquired a new stake in shares of Encompass Health Corporation (NYSE:EHC - Free Report) during the 1st quarter, according to its most recent 13F filing with the SEC. The firm acquired 11,097 shares of the company's stock, valued at approximately $1,124,000.

Other large investors have also bought and sold shares of the company. Mariner LLC lifted its position in shares of Encompass Health by 24.6% during the fourth quarter. Mariner LLC now owns 4,251 shares of the company's stock valued at $393,000 after purchasing an additional 838 shares in the last quarter. MML Investors Services LLC lifted its position in shares of Encompass Health by 11.1% during the fourth quarter. MML Investors Services LLC now owns 20,366 shares of the company's stock valued at $1,881,000 after purchasing an additional 2,039 shares in the last quarter. Stifel Financial Corp lifted its position in shares of Encompass Health by 6.4% during the 4th quarter. Stifel Financial Corp now owns 64,870 shares of the company's stock worth $5,991,000 after buying an additional 3,886 shares in the last quarter. Hsbc Holdings PLC lifted its position in shares of Encompass Health by 20.4% during the 4th quarter. Hsbc Holdings PLC now owns 41,722 shares of the company's stock worth $3,861,000 after buying an additional 7,061 shares in the last quarter. Finally, MGO One Seven LLC lifted its position in shares of Encompass Health by 17.3% during the 4th quarter. MGO One Seven LLC now owns 4,555 shares of the company's stock worth $421,000 after buying an additional 673 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors.

Encompass Health Stock Performance

Shares of EHC traded down $1.74 during mid-day trading on Friday, hitting $121.71. The stock had a trading volume of 839,898 shares, compared to its average volume of 840,934. The firm has a market cap of $12.26 billion, a P/E ratio of 23.82, a PEG ratio of 2.13 and a beta of 0.92. The business has a fifty day moving average price of $116.66 and a 200-day moving average price of $111.22. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.06 and a quick ratio of 1.06. Encompass Health Corporation has a 52 week low of $87.85 and a 52 week high of $124.67.

Encompass Health (NYSE:EHC - Get Free Report) last issued its earnings results on Monday, August 4th. The company reported $1.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.20 by $0.20. Encompass Health had a return on equity of 17.83% and a net margin of 9.22%.The firm had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.43 billion. During the same period in the previous year, the company posted $1.11 earnings per share. The business's revenue was up 12.0% on a year-over-year basis. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. On average, equities research analysts expect that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be given a $0.19 dividend. This represents a $0.76 annualized dividend and a dividend yield of 0.6%. This is an increase from Encompass Health's previous quarterly dividend of $0.17. The ex-dividend date of this dividend is Wednesday, October 1st. Encompass Health's payout ratio is presently 13.31%.

Insider Activity

In other news, EVP Patrick William Tuer sold 1,020 shares of the business's stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total value of $126,061.80. Following the sale, the executive vice president owned 18,846 shares of the company's stock, valued at $2,329,177.14. The trade was a 5.13% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 2.10% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of analysts recently commented on EHC shares. KeyCorp lifted their price target on Encompass Health from $122.00 to $135.00 and gave the stock an "overweight" rating in a report on Tuesday, May 27th. Stephens upgraded Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price target on the stock in a report on Thursday, June 5th. Wall Street Zen cut Encompass Health from a "strong-buy" rating to a "buy" rating in a research note on Friday, June 6th. UBS Group lifted their target price on Encompass Health from $130.00 to $140.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Finally, Truist Financial lifted their target price on Encompass Health from $135.00 to $140.00 and gave the stock a "buy" rating in a research note on Thursday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating and six have issued a Buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus price target of $134.00.

Read Our Latest Stock Analysis on EHC

Encompass Health Profile

(Free Report)

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

See Also

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

Should You Invest $1,000 in Encompass Health Right Now?

Before you consider Encompass Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Encompass Health wasn't on the list.

While Encompass Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.